Objective: To evaluate the cooccurrence, and predictors of remission, of general anxiety, depression, and posttraumatic stress disorder symptoms during 2-year follow-up in survivors of acute lung injury treated in an ICU. Design: Prospective cohort study, with follow-up at 3, 6, 12, and 24 months post-acute lung injury. Setting: Thirteen medical and surgical ICUs in four hospitals. Patients: Survivors among 520 patients with acute lung injury. Measurements and Main Results: The outcomes of interest were measured using the Hospital Anxiety and Depression Scale anxiety and depression subscales (scores ≥ 8 indicating substantial symptoms) and the Impact of Event Scale-Revised (scores ≥ 1.6 indicating substantial posttraumatic stress disorder symptoms). Of the 520 enrolled patients, 274 died before 3-month followup; 186 of 196 consenting survivors (95%) completed at least one Hospital Anxiety and Depression Scale and Impact of Event Scale-Revised assessment during 2-year follow-up, and most completed multiple assessments. Across follow-up time points, the prevalence of suprathreshold general anxiety, depression, and posttraumatic stress disorder symptoms ranged from 38% to 44%, 26% to 33%, and 22% to 24%, respectively; more than half of the patients had suprathreshold symptoms in at least one domain during 2-year follow-up. The majority of survivors (59%) with any suprathreshold symptoms were above threshold for two or more types of symptoms (i.e., general anxiety, depression, and/or posttraumatic stress disorder). In fact, the most common pattern involved simultaneous general anxiety, depression, and posttraumatic stress disorder symptoms. Most patients with gen-
eral anxiety, depression, or posttraumatic stress disorder symptoms during 2-year follow-up had suprathreshold symptoms at 24-month (last) follow-up. Higher Short-Form-36 physical functioning domain scores at the prior visit were associated with a greater likelihood of remission from general anxiety and posttraumatic stress disorder symptoms during follow-up. Conclusions: The majority of acute lung injury survivors had clinically significant general anxiety, depression, or posttraumatic stress disorder symptoms, and these symptoms tended to co-occur across domains. Better physical functioning during recovery predicted subsequent remission of general anxiety and posttraumatic stress disorder symptoms. (Crit Care Med 2015; 43:642-653) Key Words: acute lung injury; anxiety; assessments; depression; epidemiology; patient outcomes; posttraumatic stress disorder S urvivors of acute lung injury (ALI) and other critical illnesses frequently suffer with substantial general anxiety, depression, and posttraumatic stress disorder (PTSD) symptoms (1-3) as well as cognitive impairment (4) and muscle weakness (5) . Since these phenomena occur so frequently in survivors of critical illness (6), a task force recently suggested the term "post-intensive care syndrome" to raise awareness (7) . In previous reports, we have separately examined the prevalence or incidence, and correlates, of general anxiety, depression, and PTSD symptoms in a large cohort of ALI survivors (8) (9) (10) (11) (12) (13) . However, we have not previously examined cooccurrence of symptoms across different domains, and we are unaware of prior studies of factors that may influence remission from these symptoms; hence, these issues are the focus of the current report. With such information, clinicians may be better prepared to care for the growing number of survivors of critical illness.
MATERIALS AND METHODS

Study Population
Mechanically ventilated patients with ALI (14) were enrolled consecutively in a prospective longitudinal cohort study involving 13 medical and surgical ICUs at four hospitals in Baltimore, Maryland (ClinicalTrials.gov Identifier: NCT00300248). Specifically, we performed daily screening and enrolled mechanically ventilated patients who had acute-onset hypoxia, bilateral pulmonary infiltrates, Pao 2 /Fio 2 less than or equal to 300 mm Hg, and no clinical evidence of left atrial hypertension. Enrollment started in 2004 and ended in late 2007, with 2-year follow-up visits completed in 2010 (8) . To avoid inclusion of patients with primary neurologic disease or head trauma, neurologic specialty ICUs at the participating hospitals were excluded. Key exclusion criteria were 1) preexisting illness with a life expectancy of less than 6 months; 2) preexisting cognitive impairment (ascertained via medical records and/or proxy interview) or communication/language barriers; 3) no fixed address; 4) transfer to a study site ICU with preexisting ALI of greater than 24 hours duration; 5) greater than 5 days of mechanical ventilation before ALI; and 6) a physician order for no escalation of ICU care (e.g., no vasopressors or hemodialysis) at the time of study eligibility. The reasons for exclusion criteria 4 and 5 were that we wished to ensure collection of potentially relevant data regarding critical illness/intensive care early in the course of ALI or prior to onset of ALI.
Informed consent for follow-up was obtained after patients regained capacity, typically around the time of hospital discharge (15) . Follow-up occurred at 3, 6, 12, and 24 months after the onset of ALI (or a few weeks later-median, 3 wk; interquartile range, 0-7 wk). Trained research assistants conducted the follow-up interviews, ensuring that patients understood the questions and gave answers that were internally consistent. Most of the interviews (88%) were conducted faceto-face-at a Johns Hopkins Hospital research clinic (61%), at patients' homes (26%), or at another facility (e.g., a hospital or nursing home-13%); most patients (58%) required at least one home or other facility visit. Twelve percent of the interviews were conducted over the telephone. Patients received $25 for each visit as well as a meal coupon and taxi ride or parking voucher/mileage reimbursement. At the 24-month followup visit, patients reported retrospectively on mental health treatment since ALI. The institutional review boards of Johns Hopkins University and all participating study sites approved this research.
Definition of General Anxiety, Depression, and PTSD Symptoms
At each follow-up time point, we assessed general anxiety and depressive symptoms using the Hospital Anxiety and Depression Scale (HADS) (16, 17) . The HADS anxiety and depression subscales each consist of seven items, and each item is rated on a four-point scale; potential scores for each subscale range from 0 to 21. Patients with scores greater than or equal to 8 on each subscale are considered symptomatic with general anxiety or depressive symptoms. The greater than or equal to 8 threshold on each subscale is associated with sensitivities and specificities of ~0.8 for the detection of clinically significant anxiety or depressive syndromes in general medical patients (17) . We chose the HADS because it was developed for detecting psychiatric symptoms in patients with general medical problems. For example, the HADS depression items primarily assess anhedonia rather than neurovegetative symptoms (e.g., diminished energy) that could be symptomatic of general medical conditions (e.g., muscular weakness and fatigue) rather than depressive states.
We assessed PTSD symptoms using the Impact of Event Scale-Revised (IESR) (18) . The IESR consists of 22 items, each rated on a four-point scale; scores of all items are averaged to generate a mean total score with a potential range of 0-4. In a previous study, we examined the measurement properties of the IESR versus clinicians' structured interview-based Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) PTSD diagnostic assessments (using the Clinician-Administered PTSD Scale) (19) . At an optimal threshold of greater than or equal to 1.6, the sensitivity for detecting full DSM-IV PTSD was 100%, and the specificity was 85%; positive and negative likelihood ratios were 6.5 and 0.0, respectively (19) . Thus, we chose the greater than or equal to 1.6 threshold in the current study to define clinically significant PTSD symptoms.
Definitions of Remission and Recurrence
We defined remission from general anxiety or depression symptoms as having HADS anxiety or depression scores less than 8 at any follow-up time point after symptoms were evident along with a statistically reliable decrease in score using the Reliable Change Index (RCI) (20) . To calculate the RCI, we used sd and test-retest reliability estimates from previous studies (21, 22) . To have a statistically significant change, patients had to have a difference in scores of greater than or equal to 4; this threshold is substantially larger than the minimal clinically important difference (1.5 points) established for these subscales (23) . We defined recurrence as having an HADS anxiety or depression score greater than or equal to 8 at any follow-up after remission along with an increase in score of greater than or equal to 4.
We defined remission from PTSD symptoms as having an IESR score less than or equal to 1.6 at any follow-up time point after PTSD symptoms were evident along with a statistically reliable decrease in score using the RCI. To calculate the RCI, we used sd and test-retest reliability estimates from previous studies (24, 25) . To have a statistically significant change, patients had to have a difference in scores of greater than or equal to 0.5; note that this difference is slightly larger than that in our previous publication (13) , as we now incorporate the sd from a recent large population-based study (24) . We defined recurrence as having an IESR score greater than or equal to 1.6 at any follow-up after remission along with an increase in score of greater than or equal to 0.5.
Predictors of Remission
Based on results from prior studies of remission of PTSD and depression (26-28), we evaluated candidate baseline (pre-ALI) variables that could affect remission. These baseline variables included 1) demographic factors (age, sex, education, employment, and 2011 median income in the patient's zip code) (29-31); 2) mental health factors (a history of depression, anxiety, heavy alcohol use, or illicit drug use); 3) general health factors (evaluated using the Charlson Comorbidity Index [32] and the Functional Comorbidity Index [33] ); and 4) physical functioning, defined in two ways: a) "impaired physical function," defined as greater than or equal to two dependencies in instrumental activities of daily living (IADLs) (12, 34) and b) the Short-Form 36 (SF-36) physical function domain score (35) , normed for age and sex, with a general population mean of 50 and sd of 10. We abstracted mental and general health variables from patients' medical records, and patients/proxies provided retrospective reports regarding pre-ALI physical functioning. In abstraction of pre-ALI mental health variables, "depression" included any depression diagnosis; "anxiety" included any anxiety diagnosis, including panic disorder and PTSD; "heavy alcohol use" included any indication of problem drinking, alcohol abuse, alcoholism, or alcoholic liver disease (including cirrhosis); and "illicit drug use" included noninjection and injection illicit drug use.
We were also interested in longitudinal relationships between mental health and general health status during the 2 years of follow-up. Thus, we examined new, existing, and remitted general anxiety, depression, and PTSD symptoms at the last visit as potential predictors of remission at each subsequent visit. For example, "new depressive symptoms at the last visit" mean that patients were below threshold in the second-to-last visit but had a reliable increase in symptom score to above the instrument's threshold by the last visit. "Existing depressive symptoms" indicate that patients had depressive symptoms during the last two visits (without a reliable decrease by the last visit). "Remitted depressive symptoms" mean that patients had depressive symptoms in the secondto-last visit, but had a reliable decrease in score to below threshold by the last visit. These analyses were motivated, in part, by a prior report that anxiety and depressive disorders with onsets after PTSD predicted longer-duration PTSD episodes (26) . In addition, we examined new, existing, and remitted impaired physical function (≥ 2 IADL dependencies) and number of IADL dependencies at the last visit as potential predictors of remission at each subsequent visit. Finally, we examined last-visit SF-36 physical function domain scores as predictors of subsequent-visit remission.
Statistical Methods
We examined within-person longitudinal symptom stability using Spearman rho correlations. We also examined relationships among HADS anxiety scores, HADS depression scores, and IESR scores using Spearman rho correlations. When survivors had missing HADS anxiety, HADS depression, or IESR values during follow-up, we assumed that their prior status remained unchanged (i.e., we carried their last observation forward) as in prior work (12, 13) . Since this method is conservative when estimating remission, we supplemented this analysis with additional analyses: 1) only including data from 2-year survivors and 2) only including data from survivors with no missing data during 2-year follow-up. We used discrete time survival analysis models (36) to examine potential predictors of remission. To avoid overfitting of regression models (37), logical groupings of potential predictor variables were evaluated separately in nine small multivariable models. When more than one variable was associated with remission among these initial models, we then examined the variables associated with remission simultaneously in subsequent multivariable models. We defined statistical significance with a two-sided p value less than or equal to 0.05 and conducted all analyses using R statistical software (R Foundation for Statistical Computing, Vienna, Austria) (38) .
RESULTS
Patient Flow
A total of 520 patients with ALI were enrolled in the study; 274 of the enrolled patients (53%) died before 3-month followup ( Fig. 1) . A total of 186 of 196 consenting survivors (95%) completed at least one HADS and IESR assessment during 2-year follow-up, and most survivors completed multiple assessments (specifically, 52% had all four assessments, 24% had three, 15% had two, and 9% had only one, with death as an important cause of missed follow-up visits- Fig. 1 ). Table  1 shows pre-ALI demographic, health, and physical function characteristics in these survivors.
Critical illness/intensive care characteristics of these 186 survivors have been reported previously (12) . Briefly, most (86%) had been treated in medical ICUs; 30% had a maximum daily Sequential Organ Failure Assessment (39) score greater than 10; 21% had a mean daily midazolam equivalent dose greater than 75 mg; 29% had a mean daily prednisone equivalent dose greater than or equal to 50 mg; their mean ICU length of stay was 19 days (sd, 17 d); and almost all had been delirious or deeply sedated/comatose at some point during their ICU stay.
Notably, more than 97% of these survivors met criteria for acute respiratory distress syndrome (Pao 2 /Fio 2 ≤ 200 mm Hg) at some point during their critical illness, and 33% had Pao 2 /Fio 2 less than or equal to 100 mm Hg at some point during their critical illness.
Symptom Trajectories
Mean scores did not vary substantially over 2-year followup: the average HADS anxiety score remained around 6, the average HADS depression score remained around 5, and the average IESR score remained around 0.9 after the 3-month follow-up visit. All symptoms were highly stable longitudinally; for anxiety, within-person correlations ranged from 0.56 to 0.74 across follow-up time points; for depression, 0.48 to 0.67; for PTSD, 0.66 to 0.70. Figure 2 shows the prevalence of suprathreshold symptoms of general anxiety, depression, and PTSD during 2-year follow-up. Across all follow-up time points, general anxiety symptoms were most common (point prevalences ranged from 38% to 44%), followed by depression symptoms (26-33%) and PTSD symptoms (22-24%).
Figures 3-5 illustrate individual and mean symptom trajectories for patients who never had suprathreshold symptoms (of general anxiety, depression, and PTSD, respectively), those who had suprathreshold symptoms throughout the follow-up period, those who had a remission without recurrence, and those who had a remission and recurrence. For those with suprathreshold symptoms at any time point, the most common pattern was to have symptoms remain above threshold throughout 2-year follow-up. The next most common patterns of symptom trajectory were remission without recurrence, then remission with recurrence. Notably, 105 of the 186 patients (56%) had general anxiety symptoms at any point survivors were more likely to have remissions than onsets of general anxiety, depression, and PTSD symptoms; specifically, across follow-ups, patients were 1.2, 1.9, and 3.5 times as likely to have remissions than onsets of general anxiety, depression, and PTSD symptoms, respectively.
Survivors reported marked reductions in physical function after ALI, with gradual improvements during 2-year follow-up. Pre-ALI, survivors' mean SF-36 Physical Function score was 44 (sd, 14) ; at 3-, 6-, 12-, and 24-month follow-up visits, mean scores were 34 (13), 36 (13), 37 (13), and 39 (13), respectively.
Similarly, pre-ALI, survivors' mean number of IADL dependencies was 1.7 (sd, 2.3); at 3-, 6-, 12-, and 24-month follow-up visits, mean numbers were 3.4 (2.9), 2.7 (2.8), 2.2 (2.7), and 2.2 (2.5), respectively. Finally, pre-ALI, 38% of survivors had greater than or equal to two IADL dependencies; at 3-, 6-, 12-, and 24-month follow-up visits, 64%, 56%, 48%, and 47% had greater than or equal to two IADL dependencies, respectively.
Cooccurrence of Symptoms
HADS anxiety and depression symptoms were the most highly correlated symptoms (correlations ranged from 0.57 to 0.68 across follow-up time points), followed by HADS anxiety and PTSD symptoms (0.52-0.66), then HADS depression and PTSD symptoms (0.35-0.47); all correlations were statistically significant (p ≤ 0.001).
The majority of survivors (59%) with any suprathreshold symptoms were above threshold for two or more types of symptoms (i.e., general anxiety, depression, and/or PTSD symptoms). In fact, the most common pattern involved simultaneous general anxiety, depression, and PTSD symptoms (25%). The next most common patterns, in order, were as follows: general anxiety symptoms alone (21%), general anxiety and depression symptoms simultaneously (20%), general anxiety and PTSD symptoms simultaneously (12%), depression symptoms alone (12%), PTSD symptoms alone (8%), and depression and PTSD symptoms simultaneously (2%).
At the 24-month follow-up visit, 138 survivors reported retrospectively on mental health treatment since ALI ( Table 2) . Of those who had no suprathreshold general anxiety, depression, or PTSD symptoms during follow-up, only 12% reported taking psychiatric medications (such as for depression or anxiety), and only 8% reported receiving specialist mental healthcare. By contrast, of those who had suprathreshold symptoms in all three domains, 58% reported taking psychiatric medications, and 47% reported receiving specialist mental healthcare. In almost all cases, there was a monotonic positive relationship between the number of domains of suprathreshold mental health symptoms and receiving treatment ( Table 2) .
Predictors of Remission
At least one remission occurred for a minority of patients for each of the three mental health outcomes. Specifically, remissions occurred for 34 of 105 patients with general anxiety symptoms (32%), 26 of 85 with depression symptoms (30%), and 30 of 66 with PTSD symptoms (45%). In the subset of 2-year survivors, remissions occurred for 36%, 30%, and 52%, respectively; and in the subset of patients with no missing data during 2-year follow-up, remissions occurred for 36%, 36%, and 61%, respectively. Baseline demographic and health factors were not significantly related to remission of general anxiety, depression, or PTSD symptoms ( Table 3) . Better SF-36 physical functioning at the last follow-up visit was independently associated with remission of both general anxiety and PTSD symptoms. Although recent IADL dependencies (evident at the last visit) were negatively associated with remission of general anxiety symptoms, this relationship was no longer statistically significant when recent-onset depressive symptoms were included in a multivariable model ( 
DISCUSSION
In this multisite, 2-year prospective longitudinal cohort study of 186 ALI survivors, we found high levels of cooccurrence of general anxiety, depression, and PTSD symptoms, relatively low levels of remission, and that better physical function predicted subsequent remission from general anxiety and PTSD symptoms. Suprathreshold general anxiety, depression, and PTSD symptoms co-occurred frequently; indeed, 59% of those with any suprathreshold symptoms had them in two or more symptom domains, and having suprathreshold symptoms in more domains was associated with more mental health treatment. Our cooccurrence findings are consistent with others' recent findings in critical illness survivors (40) (41) (42) . These findings are also consistent with our clinical experience with these patients (i.e., ALI survivors referred for one psychiatric illness often meet diagnostic criteria for at least one other) and underscore the need for clinicians to assess and treat their patients for a spectrum of distress-related psychiatric phenomena if any are evident. Suprathreshold general anxiety, depression, and PTSD phenomena were long-lasting. Most ALI survivors with any suprathreshold symptoms during 2-year follow-up had them at the last follow-up visit; this was largely due to lack of remission, but it was also due, in part, to recurrence by the last follow-up visit. The most common suprathreshold symptoms were general anxiety symptoms (point prevalences, 38-44%)this is a new finding to add to our prior observations of the long-lasting/recurrent nature of depression and PTSD symptoms in this cohort (12, 13) . Notably, remissions, especially from PTSD symptoms, were more common in patients who survived to 2-year follow-up, and particularly in the 52% of initial survivors who were able to participate in all follow-up visits.
Surprisingly, baseline demographic characteristics like older age, female sex, unemployment, and lower socioeconomic status did not adversely affect remission from general anxiety, depression, or PTSD symptoms, contrary to our expectations based on the general psychiatric literature (26) (27) (28) . Further, baseline (pre-ALI) mental and general health characteristics did not predict remission, also contrary to our expectations (27, 28) . Thus, prior experience regarding remission in other patient populations may not be generalizable to ALI survivors. The only robust predictor of remission was higher SF-36 physical function domain scores at survivors' previous visit. With a five-point (i.e., half an sd) higher normed SF-36 physical function score, survivors had a 28% greater odds of remission from generalized anxiety or PTSD symptoms. These results Trajectories of Hospital Anxiety and Depression Scale (HADS) anxiety scores among acute lung injury survivors whose general anxiety symptoms remained below threshold throughout 24-month follow-up ("No Symptoms"), those whose symptoms remained above threshold throughout ("Maintainers"), those whose symptoms remitted and did not recur ("Remitters"), and those with remissions and recurrences ("Recurrence"). underscore the need to treat the whole patient, including a focus on both physical and mental health sequelae of critical illness (7) ; such attention may help ALI survivors recover more quickly. Improvements in physical functioning may promote a sense of independence/ability, as well as an increased capacity for exercise, which could positively affect emotional well-being (43, 44) . Importantly, in-ICU physical and occupational therapy appears to reduce the duration of delirium and improve patients' functional outcomes at hospital discharge (45) ; future studies of in-ICU rehabilitation should examine whether such early interventions improve survivors' long-term mental health as well.
In the current study, we did not address whether or not ALI/intensive care may be causally related to general anxiety, depression, or PTSD symptoms during follow-up. Results of other studies that used identical measures of psychiatric symptoms before and after critical illness may be of interest in this regard. In a prospective longitudinal study of patients with diabetes (the Pathways Epidemiologic Follow-up Study), Davydow et al (46) found that having a critical illness/ICU stay was independently associated with depressive symptoms at follow-up, but having depressive symptoms at baseline also increased the risk of an ICU stay during followup (47) . In a populationbased cohort study of older adults (part of the Health and Retirement Study), the prevalence of suprathreshold depressive symptoms was similar at a median of 1.2 years before and 0.9 years after an episode of severe sepsis (48) . Nevertheless, in a very large cohort study using linked data from Danish national population-based medical databases, Wunsch et al (49) found that having a psychiatric diagnosis in the prior 5 years was associated with an increased risk for critical illness (prevalence ratio, 2.7), but having a critical illness increased the risk of a new psychiatric diagnosis or psychiatric medication very substantially (hazard ratios, > 20). Thus, psychiatric symptoms may be both a risk factor for and a result of critical illness.
Several potential limitations should be considered with these results. First, we measured general anxiety, depression, and PTSD symptoms using validated questionnaires (19, 22) rather than clinical interviews incorporating multiple sources of mental health information. Because of the added respondent burden (which may have required up to 2 hr at each follow-up visit), we believe that clinical interviews would have exceeded the limits of feasibility and resulted in substantially higher losses to follow-up, especially during the first year when patients were still in early recovery and required three follow-up visits. Furthermore, obtaining clinician diagnoses and symptom ratings also would have been logistically difficult, given the need for expert clinicians to be physically present in patients' homes or long-term care facilities (58% of participants required at least one such visit during 2-yr follow-up). Second, we used medical records to identify baseline health problems. Anxiety disorders, in particular, may be underrecognized in medical records; that is, in general population studies, anxiety disorders are the most common mental illnesses (50, 51) , but in our study, anxiety disorders were recorded much less frequently than depressive disorders (6% vs 21%, respectively). Trajectories of Hospital Anxiety and Depression Scale (HADS) depression scores among acute lung injury survivors whose depression symptoms remained below threshold throughout 24-month follow-up ("No Symptoms"), those whose symptoms remained above threshold throughout ("Maintainers"), those whose symptoms remitted and did not recur ("Remitters"), and those with remissions and recurrences ("Recurrence"). Thin gray lines indicate individual trajectories, and thick black lines indicate mean trajectories. The horizontal dashed lines indicate the threshold for depression symptoms (HADS depression score ≥ 8).
Such potential bias is generally unavoidable given the infeasibility of directly assessing patients' psychiatric history prior to ALI onset. Third, we did not take into account the possible salutary effect of treatment on symptoms, and we may have missed symptom onset or remission before 3-month follow-up or in between follow-up visits. Although we collected basic information on receipt of psychiatric treatment retrospectively at 2-year follow-up, we chose not to analyze these data as a predictor of course of psychiatric symptoms, since we were concerned about confounding by indication, as well as our lack of information regarding specific treatments, timing, duration, and so on. Fourth, although we statistically controlled for potential confounders in our analysis of remission predictors, residual confounding could have influenced our findings. Nevertheless, it is not possible to randomize patients to better mental or physical function during the recovery period; thus, observational research, like this study, provides essential information regarding such associations. Fifth, we did not measure social support during patients' critical illnesses or during 2-year follow-up; strong social support may mitigate the emotional effects of a severe stressor like ALI (52, 53) . Sixth, we limited our focus to survivors of the archetypal critical illness ALI (54) , and our results may not generalize well to all populations of critical illness survivors (1) (2) (3) . Finally, future studies should examine a broader range of Figure 5 . Trajectories of Impact of Event Scale-Revised (IESR) scores among acute lung injury survivors whose posttraumatic stress disorder (PTSD) symptoms remained below threshold throughout 24-month follow-up ("No Symptoms"), those whose symptoms remained above threshold throughout ("Maintainers"), those whose symptoms remitted and did not recur ("Remitters"), and those with remissions and recurrences ("Recurrence"). Thin gray lines indicate individual trajectories, and thick black lines indicate mean trajectories. The horizontal dashed lines indicate the threshold for PTSD symptoms (IESR score ≥ 1.6). psychiatric symptoms. For example, many patients surviving a critical illness develop substantial illness anxiety (55); our clinical experience suggests that many patients develop compulsive cleaning rituals and avoidance of germs and irritants that contribute to overall dysfunction.
CONCLUSIONS
In this multisite, 2-year prospective longitudinal cohort study of 186 ALI survivors, we found high levels of comorbidity of general anxiety, depression, and PTSD symptoms, relatively low levels of remission, and that better physical function predicted subsequent remission from general anxiety and PTSD symptoms. When caring for ALI survivors, clinicians should address the full spectrum of potential mental and physical health sequelae to maximize patient recovery.
